Mastery-based learning allows students to learn at their own pace.
NYS Entity Status
NYS Filing Date
SEPTEMBER 24, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - ANDAS PHARMACEUTICAL SUPPLY CORP.
AROUND THE WEB
- A New Kind of Classroom: No Grades, No Failing, No Hurry
By KYLE SPENCER - Friday Aug 11, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Marine Corps Plane Crash: The Victims
By THE NEW YORK TIMES - Thursday Jul 13, 2017
Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.
- Could the Rockaways Survive Another Sandy?
By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017
Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.
- Apple in talks with Bain for Toshiba chip business
By Takako Taniguchi and Peter Elstrom - Thursday Aug 31, 2017
Apple is wading into the middle of the battle for Toshiba’s memory-chip business. The Cupertino iPhone maker is in talks with Bain Capital to bid for the unit, in competition with a group that includes KKR & Co. and Western Digital Corp., according to people familiar with the matter. Bain had previously submitted a $19 billion offer with another group that included state-backed Innovation Network Corp. of Japan and Development Bank of Japan. Apple depends on flash memory from Toshiba in its iPhones and iPods and wants a continued supply so it’s not dependent on rival Samsung. “There are supply shortages of that type of memory,” Michael Walkley, an analyst with Canaccord Genuity.